NEWS FEED & ADDITIVE MAGAZINE November 2023 7 Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, will launch the MEFLUVAC™ H5 PLUS 8 vaccine in partnership with ilender in Latin America to assist in building immunity against the highly pathogenic Avian Influenza. Kemin Biologics, the global veterinary vaccine division of Kemin, debuted the new vaccine in Peru at an event and roadshow held in the Peruvian cities of Lima, Trujillo, and Chincha in October. At this event, policy and distribution stakeholders, along with customers from the poultry meat and layer industries, came together to discuss vaccinology and risk management programs. The industry leaders focused on the importance of addressing major pathogens that compromise animal performance and food security for the growing population. "We are excited to introduce our technology and best practices to empower the poultry industry in Peru and Latin America to mitigate the growing threat of highly pathogenic Avian Influenza," said Dr. Ricardo Neto, Technical Service Manager, Kemin Biologics. "The high degree of homology with local strains makes MEFLUVAC™ H5 PLUS 8 the vaccine of choice." "The launch of MEFLUVAC™ H5 PLUS 8 is a major milestone for Kemin Biologics' expansion into the Latin America market," said Dr. Matias Jansen, Regional Business Director, Kemin Biologics. "Together with our partner, ilender, we will be able to reach producers all across Peru and support them with vaccination strategies that are based on our expertise and experiences from all over the world." Read more>> Kemin and Ilender launch Avian Influenza vaccine in Peru Lallemand Animal Nutrition announced the launch of Lalprobiome, its new platform of innovative microbial solutions tailored for pets. The new brand offers a broad range of yeast and bacteria-based solutions including prebiotics, probiotics, postbiotics, and antioxidants. From digestive care to immune support, and antioxidant optimization to cognitive function, Lalprobiome offers a broad range of specific solutions allowing for petfood, treat, and supplement customization and differentiation. Dr. Francesca Susca, Global Pet Product Manager, explained: “Our company is a global leader in the selection and application of microbial strains to address the nutrition and well-being of humans and animals. We’ve capitalized on this legacy to bring Lalprobiome to the pet food market. Lalprobiome leverages the natural power of yeast and bacteria with cutting-edge science to support pet health and well-being.” She added: “We understand that every business is unique, which is why we’re thrilled to launch Lalprobiome. This gives our customers the ability to elevate and differentiate their brands with novel ingredients that support unique and specific benefits. Lalprobiome products have been exhaustively tested for safety and efficacy, providing customers with proven, healthy products.” Read more>> Lallemand launches new platform of innovative microbial solutions for pets
RkJQdWJsaXNoZXIy MTUxNjkxNQ==